Publications

Insights into the middle market.

Publications

Legal Updates
  • Mark Rosenberg Authors Intellectual Property Magazine Article on New Amazon Patent Dispute Program for Sellers
    September 6, 2019

    Intellectual Property partner and co-chair of the Reputation Management practice Mark Rosenberg authored an article featured in Intellectual Property Magazine titled, “Amazon Assistance.” In the article, Mark discusses Amazon’s neutral patent evaluation program, which creates an alternative to federal court proceedings in patent infringement disputes on its website.

  • Philip Braginsky Authors MD+DI Article on Patent Considerations for Connected Medical Devices
    September 4, 2019

    Intellectual Property Group co-chair Philip Braginsky authored an article featured in Medical Device and Diagnostic Industry (MD+DI) titled, “Patent Considerations for Connected Medical Devices.” In the article, Phil discusses why developing new solutions, the Internet of Things (IoT) and Blockchain must be important components of a medtech company’s strategic planning.

  • We're Happy You Joined: Canada and Brazil Are the Most Recent Nations to Sign on to the Madrid Protocol
    July 18, 2019

    Canada and Brazil have signed on to the Madrid Protocol, which established "one-stop shopping" for filing an international trademark application. The Protocol came into effect in Canada on June 17, 2019 and will come into effect in Brazil on October 2, 2019, bringing the total of Protocol nations to 121.

  • USPTO Announces New Rule Requiring Foreign Trademark Filers to Appoint an Attorney Licensed in the United States
    July 16, 2019

    On July 2, 2019, the United States Patent and Trademark Office (USPTO) announced a new rule that all trademark applicants and registrants whose domicile or principal place of business is not located within the United States must be represented by an attorney who is an active member in good standing of the bar of the highest court of a state in the United States. This rule becomes effective on August 3, 2019.

  • Food and Drug Administration Enhances Paragraph IV Certifications List
    July 11, 2019

    The Food and Drug Administration (FDA) recently enhanced its Paragraph IV (PIV) Certifications List with additional data fields. The PIV Certification List regularly publishes information regarding the 180-day exclusivity provided under 505(j) of the Federal Food, Drug, and Cosmetic Act (FD&C Act). Historically, the information has included the name of the drug product, dosage form, strengths, RLD/NDA numbers and the date of first filing. The new data fields added by FDA will further help generic drug companies plan product development more strategically and are intended to increase approvals of more generic drugs.

Articles

Privacy Policy

We have updated our privacy policy. Click here to view.

I agree